• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HMGB1:在肝脏疾病发病机制中的作用概述。

HMGB1: An overview of its roles in the pathogenesis of liver disease.

机构信息

Department of Immunology, School of Medicine, Yangtze University, Jingzhou, Hubei Province, People's Republic of China.

Clinical Molecular Immunology Center, School of Medicine, Yangtze University, Jingzhou, Hubei Province, People's Republic of China.

出版信息

J Leukoc Biol. 2021 Nov;110(5):987-998. doi: 10.1002/JLB.3MR0121-277R. Epub 2021 Mar 30.

DOI:10.1002/JLB.3MR0121-277R
PMID:33784425
Abstract

High-mobility group box 1 (HMGB1) is an abundant architectural chromosomal protein that has multiple biologic functions: gene transcription, DNA replication, DNA-damage repair, and cell signaling for inflammation. HMGB1 can be released passively by necrotic cells or secreted actively by activated immune cells into the extracellular milieu after injury. Extracellular HMGB1 acts as a damage-associated molecular pattern to initiate the innate inflammatory response to infection and injury by communicating with neighboring cells through binding to specific cell-surface receptors, including Toll-like receptors (TLRs) and the receptor for advanced glycation end products (RAGE). Numerous studies have suggested HMGB1 to act as a key protein mediating the pathogenesis of chronic and acute liver diseases, including nonalcoholic fatty liver disease, hepatocellular carcinoma, and hepatic ischemia/reperfusion injury. Here, we provide a detailed review that focuses on the role of HMGB1 and HMGB1-mediated inflammatory signaling pathways in the pathogenesis of liver diseases.

摘要

高迁移率族蛋白 B1(HMGB1)是一种丰富的结构染色体蛋白,具有多种生物学功能:基因转录、DNA 复制、DNA 损伤修复以及炎症的细胞信号转导。HMGB1 可以通过坏死细胞被动释放,也可以在损伤后被激活的免疫细胞主动分泌到细胞外基质中。细胞外 HMGB1 作为一种损伤相关分子模式,通过与细胞表面特定受体(包括 Toll 样受体(TLRs)和晚期糖基化终产物受体(RAGE))结合,与邻近细胞进行通讯,从而启动对感染和损伤的固有炎症反应。大量研究表明,HMGB1 作为一种关键蛋白,介导慢性和急性肝病的发病机制,包括非酒精性脂肪性肝病、肝细胞癌和肝缺血/再灌注损伤。在这里,我们提供了一个详细的综述,重点介绍了 HMGB1 及其介导的炎症信号通路在肝病发病机制中的作用。

相似文献

1
HMGB1: An overview of its roles in the pathogenesis of liver disease.HMGB1:在肝脏疾病发病机制中的作用概述。
J Leukoc Biol. 2021 Nov;110(5):987-998. doi: 10.1002/JLB.3MR0121-277R. Epub 2021 Mar 30.
2
Role of High-Mobility Group Box-1 in Liver Pathogenesis.高迁移率族蛋白 B1 在肝脏发病机制中的作用。
Int J Mol Sci. 2019 Oct 25;20(21):5314. doi: 10.3390/ijms20215314.
3
High-Mobility Group Box-1 and Liver Disease.高迁移率族蛋白盒1与肝脏疾病
Hepatol Commun. 2018 Sep 7;2(9):1005-1020. doi: 10.1002/hep4.1223. eCollection 2018 Sep.
4
Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling.揭示高迁移率族蛋白 B1(HMGB1)在炎症中的作用:受体信号转导的最新进展。
Eur J Pharmacol. 2019 Sep 5;858:172487. doi: 10.1016/j.ejphar.2019.172487. Epub 2019 Jun 20.
5
An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies.HMGB1 抑制剂作为 HMGB1 相关疾病潜在治疗药物的概述。
Pharmacol Ther. 2014 Mar;141(3):347-57. doi: 10.1016/j.pharmthera.2013.11.001. Epub 2013 Nov 9.
6
The myocardial infarct-exacerbating effect of cell-free DNA is mediated by the high-mobility group box 1-receptor for advanced glycation end products-Toll-like receptor 9 pathway.无细胞游离 DNA 的心肌梗死加重作用是通过高迁移率族蛋白 B1-晚期糖基化终产物受体-Toll 样受体 9 通路介导的。
J Thorac Cardiovasc Surg. 2019 Jun;157(6):2256-2269.e3. doi: 10.1016/j.jtcvs.2018.09.043. Epub 2018 Oct 5.
7
High-mobility group protein box-1 and its relevance to cerebral ischemia.高迁移率族蛋白盒-1 及其与脑缺血的相关性。
J Cereb Blood Flow Metab. 2010 Feb;30(2):243-54. doi: 10.1038/jcbfm.2009.202. Epub 2009 Sep 30.
8
High Mobility Group Box-1 Drives Fibrosis Progression Signaling via the Receptor for Advanced Glycation End Products in Mice.高迁移率族蛋白 B1 通过糖基化终产物受体驱动小鼠纤维化进程信号转导。
Hepatology. 2018 Dec;68(6):2380-2404. doi: 10.1002/hep.30093. Epub 2018 Nov 13.
9
Extracellular high-mobility group box 1 protein (HMGB1) as a mediator of persistent pain.细胞外高迁移率族蛋白B1(HMGB1)作为持续性疼痛的介质。
Mol Med. 2015 Feb 5;20(1):569-78. doi: 10.2119/molmed.2014.00176.
10
Review: Therapeutic Targeting of HMGB1 in Stroke.综述:中风中高迁移率族蛋白B1的治疗靶点
Curr Drug Deliv. 2017 Sep 6;14(6):785-790. doi: 10.2174/1567201813666160808111933.

引用本文的文献

1
Berberine protects against gefitinib-induced liver injury by inhibiting the HMGB1/TLR4/NF-κB pathway.小檗碱通过抑制HMGB1/TLR4/NF-κB通路来预防吉非替尼诱导的肝损伤。
Front Pharmacol. 2025 Aug 26;16:1645634. doi: 10.3389/fphar.2025.1645634. eCollection 2025.
2
Effects of Adipose-Derived Mesenchymal Stem Cell-Secretome on Pyroptosis of Laparoscopic Hepatic Ischemia Reperfusion Injury in a Porcine Model.脂肪间充质干细胞分泌组对猪腹腔镜肝缺血再灌注损伤细胞焦亡的影响
Cells. 2025 May 15;14(10):722. doi: 10.3390/cells14100722.
3
Repositioning Perindopril for Mitigation of Methotrexate-Induced Hepatotoxicity in Rats.
重新定位培哚普利以减轻大鼠甲氨蝶呤诱导的肝毒性
Pharmaceuticals (Basel). 2025 Mar 2;18(3):358. doi: 10.3390/ph18030358.
4
Curcumin's Protective Role in Heatstroke-Induced Acute Liver Injury: Targeting Pyroptosis and Enhancing SIRT1 Expression.姜黄素在中暑诱导的急性肝损伤中的保护作用:靶向细胞焦亡并增强SIRT1表达
Glob Chall. 2024 Oct 13;8(12):2400178. doi: 10.1002/gch2.202400178. eCollection 2024 Dec.
5
Emerging Roles of High-mobility Group Box-1 in Liver Disease.高迁移率族蛋白B1在肝脏疾病中的新作用
J Clin Transl Hepatol. 2024 Dec 28;12(12):1043-1056. doi: 10.14218/JCTH.2024.00317. Epub 2024 Oct 22.
6
Sinusoidal communication in chronic liver disease.慢性肝病中的窦状隙通讯
Clin Mol Hepatol. 2025 Jan;31(1):32-55. doi: 10.3350/cmh.2024.0734. Epub 2024 Oct 2.
7
Hepatocyte activation and liver injury following cerebral ischemia promote HMGB1-mediated hepcidin upregulation in hepatocytes and regulation of systemic iron levels.脑缺血后肝细胞的激活和损伤促进了 HMGB1 介导的肝细胞内铁调素的上调和系统铁水平的调节。
Exp Mol Med. 2024 Oct;56(10):2171-2183. doi: 10.1038/s12276-024-01314-y. Epub 2024 Oct 1.
8
Immunohistochemical analyses reveal FoxP3 expressions in spleen and colorectal cancer in mice treated with AOM/DSS, and their suppression by glycyrrhizin.免疫组织化学分析显示,奥沙利铂/葡聚糖硫酸钠处理的小鼠脾脏和结直肠癌中 FoxP3 的表达,并被甘草酸所抑制。
PLoS One. 2024 Aug 16;19(8):e0307038. doi: 10.1371/journal.pone.0307038. eCollection 2024.
9
Key role of interferon regulatory factor 1 (IRF-1) in regulating liver disease: progress and outlook.干扰素调节因子 1(IRF-1)在调节肝脏疾病中的关键作用:进展与展望。
J Zhejiang Univ Sci B. 2024 Jun 15;25(6):451-470. doi: 10.1631/jzus.B2300159.
10
Steatotic Donor Transplant Livers: Preservation Strategies to Mitigate against Ischaemia-Reperfusion Injury.脂肪变性供体肝移植:减轻缺血再灌注损伤的保护策略。
Int J Mol Sci. 2024 Apr 24;25(9):4648. doi: 10.3390/ijms25094648.